Dengue
Showing 26 - 50 of 657
Dengue Trial in Singapore (Biological (Male Wolbachia-infected Aedes aegypti))
Recruiting
- Dengue
- Biological (Male Wolbachia-infected Aedes aegypti)
-
Singapore, SingaporeNational Environment Agency
Aug 16, 2022
Dengue Virus, Dengue Fever, Dengue Hemorrhagic Fever Trial in Bangkok (CYD Dengue Vaccine, Inactivated rabies virus vaccine,
Completed
- Dengue Virus
- +3 more
- CYD Dengue Vaccine
- +2 more
-
Bangkok, ThailandSanofi Pasteur Investigational Site
Mar 10, 2022
Dengue Virus, Dengue Fever, Dengue Hemorrhagic Fever Trial in Long Xuyên (CYD dengue vaccine serotypes (1, 2, 3, 4).,
Completed
- Dengue Virus
- +3 more
- CYD dengue vaccine serotypes (1, 2, 3, 4).
- Meningococcal Polysaccharide A+C; NaCl; Typhoid Vi polysaccharide
-
Long Xuyên, An Giang Province, VietnamSanofi Pasteur Investigational Site
Mar 15, 2022
Dengue Virus, Dengue Fever, Dengue Hemorrhagic Fever Trial in Chulucanas Morropon (CYD Dengue Vaccine Serotypes 1, 2, 3, and 4,
Completed
- Dengue Virus
- +3 more
- CYD Dengue Vaccine Serotypes 1, 2, 3, and 4
- Pneumococcal polysaccharide vaccine
-
Chulucanas Morropon, Piura, Peru(unnamed)
Mar 10, 2022
Dengue Trial in Syracuse (Dengue virus 3 Live Virus Human Challenge (DENV-3-LVHC))
Completed
- Dengue
- Dengue virus 3 Live Virus Human Challenge (DENV-3-LVHC)
-
Syracuse, New YorkState University of New York, Upstate Medical University (SUNY-U
Jun 10, 2022
Dengue, Dengue Fever, Dengue Hemorrhagic Fever Trial in India (Live, attenuated, recombinant dengue serotype 1, 2, 3, 4 virus,
Completed
- Dengue
- +2 more
- Live, attenuated, recombinant dengue serotype 1, 2, 3, 4 virus
- Placebo: NaCl 0.9% solution
-
Bangalore, Karnataka, India
- +4 more
Mar 15, 2022
Dengue, Dengue Hemorrhagic Fever, Dengue Virus Trial in Worldwide (CYD Dengue Vaccine, Tetanus Toxoid Reduced Diphtheria Toxoid
Completed
- Dengue
- +3 more
- CYD Dengue Vaccine
- Tetanus Toxoid Reduced Diphtheria Toxoid Acellular Pertussis
-
Bucaramanga, Colombia
- +3 more
Mar 15, 2022
Dengue, Dengue Fever, Dengue Hemorrhagic Fever Trial in Syracuse (CYD Dengue Vaccine, Japanese Encephalitis Vaccine)
Completed
- Dengue
- +2 more
- CYD Dengue Vaccine
- Japanese Encephalitis Vaccine
-
Syracuse, New York(unnamed)
Mar 15, 2022
Dengue, Dengue Fever, Dengue Hemorrhagic Fever Trial in United States (Live, attenuated, recombinant dengue serotypes 1, 2, 3,
Completed
- Dengue
- +3 more
- Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus
- Yellow Fever
-
Alabaster, Alabama
- +6 more
Mar 15, 2022
Dengue Fever, Dengue Hemorrhagic Fever, Human Papillomavirus Disease Trial in Mexico City (CYD Dengue Vaccine, Human
Completed
- Dengue Fever
- +2 more
- CYD Dengue Vaccine
- Human Papillomavirus Bivalent [Types 16 and 18] Vaccine, Recombinant
-
Mexico City, Mexico(unnamed)
Mar 15, 2022
Dengue Fever, Dengue Hemorrhagic Fever, Dengue Virus Trial in Singapore (CYD Dengue vaccine, NaCl + influenza virus or hepatitis
Completed
- Dengue Fever
- +3 more
- CYD Dengue vaccine
- NaCl + influenza virus or hepatitis A vaccine
-
Singapore, Singapore
- +4 more
Mar 10, 2022
Dengue, Dengue Hemorrhagic Fever Trial in Vitória (Live, attenuated, recombinant dengue serotype 1 , 2, 3 , and 4 virus, NaCl
Completed
- Dengue
- Dengue Hemorrhagic Fever
- Live, attenuated, recombinant dengue serotype 1 , 2, 3 , and 4 virus
- +3 more
-
Vitória, Brazil(unnamed)
Mar 10, 2022
Dengue Fever, Dengue Hemorrhagic Fever Trial in Malaysia (Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus,
Completed
- Dengue Fever
- Dengue Hemorrhagic Fever
- Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus
- Placebo: NaCl 0.9%
-
Ipoh, Perak, Malaysia
- +3 more
Mar 15, 2022
Lymphocyte Count and High Fluorescent Count Correlate With Liver
Recruiting
- Dengue Fever
- Blood and Liver Function test
-
Sukoharjo, Central Java, Indonesia
- +1 more
Jun 1, 2022
Dengue, Dengue Hemorrhagic Fever Trial in Mexico (Live, attenuated, recombinant dengue serotype 1, 2, 3, and 4 virus, DTaP
Completed
- Dengue
- Dengue Hemorrhagic Fever
- Live, attenuated, recombinant dengue serotype 1, 2, 3, and 4 virus
- +4 more
-
Acapulco, Guerrero, Mexico
- +3 more
Mar 15, 2022
Dengue Fever, Dengue Hemorrhagic Fever Trial in Singapore (CYD Dengue Vaccine (5 dose formulation), Placebo, NaCl 0.9%)
Completed
- Dengue Fever
- Dengue Hemorrhagic Fever
- CYD Dengue Vaccine (5 dose formulation)
- Placebo, NaCl 0.9%
-
Singapore, Singapore
- +2 more
Mar 15, 2022
Dengue Trial in Singapore (Serious game, Dengue prevention website)
Completed
- Dengue
- Serious game
- Dengue prevention website
-
Singapore, SingaporeSingHealth Polyclinics - Sengkang
Mar 29, 2022
Dengue Fever, Dengue Hemorrhagic Fever Trial in Philippines (CYD Dengue Vaccine, Tdap: Tetanus Toxoid, Reduced Diphtheria Toxoid
Terminated
- Dengue Fever
- Dengue Hemorrhagic Fever
- CYD Dengue Vaccine
- +2 more
-
Muntinlupa, Alabang, Philippines
- +3 more
Mar 15, 2022
Dengue, Dengue Hemorrhagic Fever, Yellow Fever Trial in Cali, Lima (Live, attenuated dengue serotype 1, 2, 3, and 4 virus,
Completed
- Dengue
- +2 more
- Live, attenuated dengue serotype 1, 2, 3, and 4 virus
- +8 more
-
Cali, Colombia
- +1 more
Mar 15, 2022
Dengue Fever, Dengue Hemorrhagic Fever, Human Papillomavirus Disease Trial in Malaysia (CYD Dengue Vaccine, Human Papillomavirus
Completed
- Dengue Fever
- +2 more
- CYD Dengue Vaccine
- Human Papillomavirus Quadrivalent [Types 6, 11, 16, and 18] Vaccine, Recombinant.
-
Klang, Malaysia
- +4 more
Mar 15, 2022
Dengue Trial in Baltimore (Dengue 4 Live Virus Human Challenge (DENV-4-LVHC) - Low Dose, Dengue 4 Live Virus Human Challenge
Recruiting
- Dengue
- Dengue 4 Live Virus Human Challenge (DENV-4-LVHC) - Low Dose
- +2 more
-
Baltimore, MarylandUniversity of Maryland, Baltimore, Center for Vaccine Developmen
Mar 1, 2022
Dengue Trial in Medellín (Educational nursing intervention)
Not yet recruiting
- Dengue
- Educational nursing intervention
-
Medellín, Antioquia, ColombiaYolima Judith Llorente Perez
Apr 1, 2022
Dengue Fever, Dengue Hemorrhagic Fever Trial in Worldwide (CYD Dengue Vaccine (5-dose formulation), Placebo, NaCl 0.9%)
Completed
- Dengue Fever
- Dengue Hemorrhagic Fever
- CYD Dengue Vaccine (5-dose formulation)
- Placebo, NaCl 0.9%
-
Vitoria, Brazil
- +4 more
Mar 15, 2022